IL18 and Miyoshi myopathy: In this study we show for the first time that only combined IL-12 and IL-18 treatment significantly increases CD25, α chain of IL-2 receptor, on NK cells and both their subsets in HC, as well as in MM patients resulting in a constitution of functional high-affinity IL-2R (IL-2Rαβγ).